NEFL and Parkinson disease: Given the potential of blood p-tau181 and NfL to predict cognitive decline in PD, the aim of this study is to investigate the association of plasma p-tau181 with cognitive performance in patients with PD, and to compare its utility as a prognostic marker for CI both alongside and relative to NfL.